BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 28911233)

  • 21. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
    Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
    Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The CRISPR-Cas9 Genome Editing System: Not as Precise as Previously Believed.
    Mattei TA
    World Neurosurg; 2018 Oct; 118():377-378. PubMed ID: 30114543
    [No Abstract]   [Full Text] [Related]  

  • 23. Multiplex conditional mutagenesis in zebrafish using the CRISPR/Cas system.
    Yin L; Maddison LA; Chen W
    Methods Cell Biol; 2016; 135():3-17. PubMed ID: 27443918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Programmable base editing of zebrafish genome using a modified CRISPR-Cas9 system.
    Zhang Y; Qin W; Lu X; Xu J; Huang H; Bai H; Li S; Lin S
    Nat Commun; 2017 Jul; 8(1):118. PubMed ID: 28740134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of genomic sites for CRISPR/Cas9-based genome editing in the Vitis vinifera genome.
    Wang Y; Liu X; Ren C; Zhong GY; Yang L; Li S; Liang Z
    BMC Plant Biol; 2016 Apr; 16():96. PubMed ID: 27098585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Application of machine learning in the CRISPR/Cas9 system].
    Zhang GS; Yang Y; Zhang LM; Dai XH
    Yi Chuan; 2018 Sep; 40(9):704-723. PubMed ID: 30369475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CRISPR-Cas9 gene editing: Delivery aspects and therapeutic potential.
    Oude Blenke E; Evers MJ; Mastrobattista E; van der Oost J
    J Control Release; 2016 Dec; 244(Pt B):139-148. PubMed ID: 27498021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CRISPR/Cas9 system produces specific and homozygous targeted gene editing in rice in one generation.
    Zhang H; Zhang J; Wei P; Zhang B; Gou F; Feng Z; Mao Y; Yang L; Zhang H; Xu N; Zhu JK
    Plant Biotechnol J; 2014 Aug; 12(6):797-807. PubMed ID: 24854982
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inducible CRISPR genome-editing tool: classifications and future trends.
    Dai X; Chen X; Fang Q; Li J; Bai Z
    Crit Rev Biotechnol; 2018 Jun; 38(4):573-586. PubMed ID: 28936886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
    Doetschman T; Georgieva T
    Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficient Genome Editing in Chicken DF-1 Cells Using the CRISPR/Cas9 System.
    Bai Y; He L; Li P; Xu K; Shao S; Ren C; Liu Z; Wei Z; Zhang Z
    G3 (Bethesda); 2016 Apr; 6(4):917-23. PubMed ID: 26869617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plant genome engineering in full bloom.
    Lozano-Juste J; Cutler SR
    Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sharpening the Scissors: Mechanistic Details of CRISPR/Cas9 Improve Functional Understanding and Inspire Future Research.
    Raper AT; Stephenson AA; Suo Z
    J Am Chem Soc; 2018 Sep; 140(36):11142-11152. PubMed ID: 30160947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of on-target and off-target mutations generated by CRISPR/Cas9 and other sequence-specific nucleases.
    Zischewski J; Fischer R; Bortesi L
    Biotechnol Adv; 2017; 35(1):95-104. PubMed ID: 28011075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue-specific gene targeting using CRISPR/Cas9.
    Ablain J; Zon LI
    Methods Cell Biol; 2016; 135():189-202. PubMed ID: 27443926
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The application of CRISPR-Cas9 genome editing in Caenorhabditis elegans.
    Xu S
    J Genet Genomics; 2015 Aug; 42(8):413-21. PubMed ID: 26336798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro CRISPR-Cas9-mediated efficient Ad5 vector modification.
    Tang L; Gong M; Zhang P
    Biochem Biophys Res Commun; 2016 May; 474(2):395-399. PubMed ID: 27125457
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Next Generation Prokaryotic Engineering: The CRISPR-Cas Toolkit.
    Mougiakos I; Bosma EF; de Vos WM; van Kranenburg R; van der Oost J
    Trends Biotechnol; 2016 Jul; 34(7):575-587. PubMed ID: 26944793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-Wide Off-Target Analysis in CRISPR-Cas9 Modified Mice and Their Offspring.
    Dong Y; Li H; Zhao L; Koopman P; Zhang F; Huang JX
    G3 (Bethesda); 2019 Nov; 9(11):3645-3651. PubMed ID: 31492696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo CRISPR editing with no detectable genome-wide off-target mutations.
    Akcakaya P; Bobbin ML; Guo JA; Malagon-Lopez J; Clement K; Garcia SP; Fellows MD; Porritt MJ; Firth MA; Carreras A; Baccega T; Seeliger F; Bjursell M; Tsai SQ; Nguyen NT; Nitsch R; Mayr LM; Pinello L; Bohlooly-Y M; Aryee MJ; Maresca M; Joung JK
    Nature; 2018 Sep; 561(7723):416-419. PubMed ID: 30209390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.